IBM and the U.S. Department of Commerce announced a Letter of Intent on May 21, 2026, to create Anderon, described as America’s first pure-play quantum chip foundry, headquartered in Albany, New York. The project is backed by a proposed $1 billion in CHIPS incentives from the Commerce Department and $1 billion in cash from IBM, plus additional intellectual property, assets, and workforce contributions. Anderon is positioned as a standalone 300mm quantum wafer fabrication facility that will initially support superconducting qubit and supporting electronics wafers, with plans to expand into other quantum modalities over time.
The announcement is part of a broader $2 billion CHIPS quantum package distributed across nine companies. IBM received the largest share, while GlobalFoundries was awarded $375 million and several other companies, including D-Wave Quantum, Rigetti Computing, Infleqtion, Atom Computing, PsiQuantum, Quantinuum, and Diraq, received smaller equity-based awards. The government will also receive minority equity stakes in each of the nine companies, extending a deal structure similar to recent federal investments in other strategic technology sectors. Commerce Secretary Howard Lutnick said the investments are intended to strengthen domestic industry, create high-paying U.S. jobs, and advance American quantum capabilities.
Analyst Brendan Burke argues that the structure of the funding reveals a deliberate two-tier strategy. The largest manufacturing-scale investment is concentrated in IBM’s 300mm superconducting silicon platform, while smaller equity stakes are spread across competing approaches such as trapped ion, photonic, and neutral atom technologies. In this view, the government is betting that superconducting silicon is the most fabrication-ready modality because it can leverage semiconductor-style manufacturing infrastructure already built for classical chips. The package, therefore, is not an even distribution of support but a hierarchy that favors production-scale infrastructure over research-stage development.
The difference between 300mm and 200mm fabrication is central to the thesis. IBM’s 300mm Albany NanoTech model is designed for high-throughput, highly automated production and rapid iteration, while 200mm facilities are better suited to smaller-volume, hands-on research. Burke says the 300mm approach can accelerate device output and shorten development cycles in ways that 200mm facilities cannot match without major new investment. GlobalFoundries’ award suggests the government also sees room for a second 300mm-capable quantum fabrication base.
The article also frames the competition between superconducting qubits and trapped-ion systems as a manufacturing question, not just a physics question. Superconducting qubits benefit from decades of semiconductor tooling, process integration, and wafer-scale production methods. Trapped-ion and other alternative platforms require different infrastructure and cannot tap the same manufacturing ecosystem. The CHIPS package’s mix of infrastructure capital and equity investments reflects that divide.
A further focus is IBM’s plan to pair qubit fabrication with classical control electronics. Anderon will support the production of wafers for supporting electronics, and IBM is developing four custom ASICs for quantum control. The company says these circuits are necessary to scale fault-tolerant quantum systems and manage power consumption at larger system sizes. The article concludes that Anderon may matter as much for the control-layer hardware it enables as for the qubit wafers it produces, and that the funding structure could shape which quantum architectures survive the transition from laboratory prototypes to industrial-scale products.
